Norges Bank’s Praxis Precision Medicines PRAX Stock Holding History

Norges Bank’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$116M	Buy	+346,969	New	+$110M	0.01%	724
2026 Q1	–	Sell	-4,354	Closed	-$1.28M	–	1044
2025 Q4	$1.28M	Buy	+4,354	New	+$811K	﹤0.01%	1483
2025 Q3	–	Sell	-5,000	Closed	-$210K	–	1167
2025 Q2	$210K	Sell	5,000 -79,200	-94%	-$3.02M	﹤0.01%	1689
2025 Q1	$3.19M	Sell	84,200 -34,700	-29%	-$2.17M	﹤0.01%	1439
2024 Q4	$9.15M	Buy	118,900 +113,900	+2,278%	+$8.24M	﹤0.01%	1372
2024 Q3	$288K	Sell	5,000 -27,005	-84%	-$1.46M	﹤0.01%	1816
2024 Q2	$1.32M	Buy	32,005 +27,005	+540%	+$1.28M	﹤0.01%	1788
2024 Q1	$305K	Buy	+5,000	New	+$224K	﹤0.01%	1859

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Norges Bank's PRAX Position: Q2 2026 in Review

Norges Bank opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 346,969 shares worth $116M. The stake represents 0.01% of the portfolio and ranks #724 among its holdings. This is a return to the name: Norges Bank previously reported a position in PRAX as recently as Q4 2025.

Norges Bank first reported a position in PRAX in Q1 2024 and has held it in 8 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Norges Bank held 346,969 shares of Praxis Precision Medicines worth $116M as of Q2 2026.
Praxis Precision Medicines was a new Norges Bank position in Q2 2026.
Praxis Precision Medicines made up 0.01% of Norges Bank's portfolio in Q2 2026, its #724 holding.
Norges Bank first reported a position in Praxis Precision Medicines in Q1 2024 and has held it in 8 quarters since.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.